tiprankstipranks
Spruce Biosciences (SPRB)
NASDAQ:SPRB
US Market

Spruce Biosciences (SPRB) Financial Statements

277 Followers

Spruce Biosciences Financial Overview

Spruce Biosciences's market cap is currently ―. The company's EPS TTM is $-1.145; its P/E ratio is -0.50; Spruce Biosciences is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 2.00M$ 2.80M$ 3.07M$ 2.20M$ 2.00M
Gross Profit$ 2.00M$ 2.80M$ 3.10M$ 2.20M$ 2.00M
EBIT$ -11.53M$ -10.06M$ -12.47M$ -12.66M$ -13.16M
EBITDA$ -11.52M$ -10.06M$ -12.47M-$ -13.33M
Net Income Common Stockholders$ -11.63M$ -9.95M$ -12.35M$ -12.79M$ -12.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 81.15M$ 96.34M$ 108.03M$ 120.52M$ 118.58M
Total Assets$ 87.54M$ 103.95M$ 112.98M$ 125.96M$ 139.11M
Total Debt$ 3.89M$ 4.36M$ 3.73M$ 4.13M$ 4.52M
Net Debt$ -77.26M$ -91.98M$ -104.30M$ -116.39M$ -114.06M
Total Liabilities$ 20.91M$ 27.44M$ 27.60M$ 29.40M$ 31.11M
Stockholders Equity$ 66.62M$ 76.51M$ 85.38M$ 96.56M$ 108.00M
Cash Flow-
Free Cash Flow$ -14.96M$ -11.21M$ -12.28M-$ -11.79M
Operating Cash Flow$ -14.96M$ -11.21M$ -12.27M$ 1.99M$ -11.79M
Investing Cash Flow-$ 9.30M$ 13.99M$ 22.00M$ 10.48M
Financing Cash Flow$ -227.00K$ -552.00K$ -405.00K$ -432.00K$ 50.53M
Currency in USD

Spruce Biosciences Earnings and Revenue History

Spruce Biosciences Debt to Assets

Spruce Biosciences Cash Flow

Spruce Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis